Literature DB >> 22592714

Patient education and counselling for promoting adherence to treatment for tuberculosis.

James Machoki M'imunya1, Tamara Kredo, Jimmy Volmink.   

Abstract

BACKGROUND: Non-adherence to tuberculosis treatment can lead to prolonged periods of infectiousness, relapse, emergence of drug-resistance, and increased morbidity and mortality. In this review, we assess whether patient education or counselling, or both, promotes adherence to tuberculosis treatment.
OBJECTIVES: To evaluate the effects of patient education or counselling, or both, on treatment completion and cure in people requiring treatment for active or latent tuberculosis. SEARCH
METHODS: Without language restriction, we searched for eligible studies in the Cochrane Infectious Diseases Group Specialized Register, Cochrane Central Register of Controlled Trials, MEDLINE, EMBASE, and LILACS; checked reference lists of relevant articles; and contacted relevant researchers and organizations up to 24 November 2011. SELECTION CRITERIA: Randomized controlled trials examining the effects of education or counselling, or both, on treatment completion and cure in people with clinical tuberculosis; and treatment completion and clinical tuberculosis in people with latent disease. DATA COLLECTION AND ANALYSIS: We independently screened identified studies for eligibility, assessed methodological quality, and extracted data; with differences resolved by consensus. We expressed study results as risk ratios (RRs) with 95% confidence intervals (CI). MAIN
RESULTS: We found three trials, with a total of 1437 participants, which examined the effects of different educational and counselling interventions on adherence to treatment for latent tuberculosis.All three trials reported the proportion of people who successfully completed treatment for latent tuberculosis. Overall, education or counselling interventions may increase successful treatment completion but the magnitude of benefit is likely to vary depending on the nature of the intervention, and the setting (data not pooled, 923 participants, three trials, low quality evidence).In a four-arm trial in children from Spain, counselling by nurses via telephone increased the proportion of children completing treatment from 65% to 94% (RR 1.44, 95% CI 1.21 to 1.72; 157 participants, one trial), and counselling by nurses through home visits increased completion to 95% (RR 1.46, 95% CI 1.23 to 1.74; 156 participants, one trial). Both of these interventions were superior to counselling by physicians at the tuberculosis clinic (RR 1.20, 95% CI 0.98 to 1.47; 159 participants, one trial).In the USA, a programme of peer counselling for adolescents failed to show an effect on treatment completion rates at six months (RR 1.01, 95% CI 0.90 to 1.13; 394 participants, one trial). In this trial treatment completion was around 75% even in the control group.In the third study, in prisoners from the USA, treatment completion was very low in the control group (12%), and although counselling significantly improved this, completion in the intervention group remained low at 24% (RR 1.94, 95% CI 1.03 to 3.68; 211 participants, one trial).None of these trials aimed to assess the effect of these interventions on the subsequent development of active tuberculosis, and we found no trials that assessed the effects of patient education or counselling on adherence to treatment for active tuberculosis. AUTHORS'
CONCLUSIONS: Educational or counselling interventions may improve completion of treatment for latent tuberculosis. As would be expected, the magnitude of the benefit is likely to depend on the nature of the intervention, and the reasons for low completion rates in the specific setting.

Entities:  

Mesh:

Year:  2012        PMID: 22592714      PMCID: PMC6532681          DOI: 10.1002/14651858.CD006591.pub2

Source DB:  PubMed          Journal:  Cochrane Database Syst Rev        ISSN: 1361-6137


  36 in total

1.  Patient education. American Academy of Family Physicians.

Authors: 
Journal:  Am Fam Physician       Date:  2000-10-01       Impact factor: 3.292

2.  Predictors of adherence to treatment for latent tuberculosis infection in high-risk Latino adolescents: a behavioral epidemiological analysis.

Authors:  Melbourne Hovell; Elaine Blumberg; Laura Gil-Trejo; Alicia Vera; Norma Kelley; Carol Sipan; C Richard Hofstetter; Sandra Marshall; Jill Berg; Lawrence Friedman; Antonino Catanzaro; Kathleen Moser
Journal:  Soc Sci Med       Date:  2003-04       Impact factor: 4.634

3.  A randomised trial of the impact of counselling on treatment adherence of tuberculosis patients in Sialkot, Pakistan.

Authors:  R Liefooghe; C Suetens; H Meulemans; M B Moran; A De Muynck
Journal:  Int J Tuberc Lung Dis       Date:  1999-12       Impact factor: 2.373

Review 4.  Isoniazid for preventing tuberculosis in non-HIV infected persons.

Authors:  M J Smieja; C A Marchetti; D J Cook; F M Smaill
Journal:  Cochrane Database Syst Rev       Date:  2000

5.  Randomized controlled trial of interventions to improve follow-up for latent tuberculosis infection after release from jail.

Authors:  Mary Castle White; Jacqueline P Tulsky; Joe Goldenson; Carmen J Portillo; Masae Kawamura; Enrique Menendez
Journal:  Arch Intern Med       Date:  2002-05-13

6.  A randomized, controlled trial of interventions to improve adherence to isoniazid therapy to prevent tuberculosis in injection drug users.

Authors:  R E Chaisson; G L Barnes; J Hackman; L Watkinson; L Kimbrough ; S Metha; S Cavalcante; R D Moore
Journal:  Am J Med       Date:  2001-06-01       Impact factor: 4.965

7.  [Educational strategy for improving patient compliance with the tuberculosis treatment regimen in Chiapas, Mexico].

Authors:  Guadalupe del Carmen Alvarez Gordillo; Julio Félix Alvarez Gordillo; José Eugenio Dorantes Jiménez
Journal:  Rev Panam Salud Publica       Date:  2003-12

8.  Increasing Latino adolescents' adherence to treatment for latent tuberculosis infection: a controlled trial.

Authors:  Melbourne F Hovell; Carol L Sipan; Elaine J Blumberg; C Richard Hofstetter; Donald Slymen; Lawrence Friedman; Kathleen Moser; Norma J Kelley; Alicia Y Vera
Journal:  Am J Public Health       Date:  2003-11       Impact factor: 9.308

9.  Tuberculosis prevention project.

Authors:  M D Barnwell; R Chitkara; F Lamberta
Journal:  J Natl Med Assoc       Date:  1992-12       Impact factor: 1.798

10.  Behavioral interventions for the control of tuberculosis among adolescents.

Authors:  D E Morisky; C K Malotte; V Ebin; P Davidson; D Cabrera; P T Trout; A Coly
Journal:  Public Health Rep       Date:  2001 Nov-Dec       Impact factor: 2.792

View more
  48 in total

1.  Priorities among HIV-positive individuals for tuberculosis preventive therapies.

Authors:  H-Y Kim; C F Hanrahan; D W Dowdy; N A Martinson; J E Golub; J F P Bridges
Journal:  Int J Tuberc Lung Dis       Date:  2020-04-01       Impact factor: 2.373

2.  Improving outcomes for multi-drug-resistant tuberculosis in the Peruvian Amazon - a qualitative study exploring the experiences and perceptions of patients and healthcare professionals.

Authors:  Thomas W McNally; Gilles de Wildt; Graciela Meza; Connie M D Wiskin
Journal:  BMC Health Serv Res       Date:  2019-08-22       Impact factor: 2.655

3.  Official American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America Clinical Practice Guidelines: Treatment of Drug-Susceptible Tuberculosis.

Authors:  Payam Nahid; Susan E Dorman; Narges Alipanah; Pennan M Barry; Jan L Brozek; Adithya Cattamanchi; Lelia H Chaisson; Richard E Chaisson; Charles L Daley; Malgosia Grzemska; Julie M Higashi; Christine S Ho; Philip C Hopewell; Salmaan A Keshavjee; Christian Lienhardt; Richard Menzies; Cynthia Merrifield; Masahiro Narita; Rick O'Brien; Charles A Peloquin; Ann Raftery; Jussi Saukkonen; H Simon Schaaf; Giovanni Sotgiu; Jeffrey R Starke; Giovanni Battista Migliori; Andrew Vernon
Journal:  Clin Infect Dis       Date:  2016-08-10       Impact factor: 9.079

4.  Getting to 90-90-90 in paediatric HIV: What is needed?

Authors:  Mary-Ann Davies; Jorge Pinto; Marlène Bras
Journal:  J Int AIDS Soc       Date:  2015-12-02       Impact factor: 5.396

5.  Acceptability, feasibility, and impact of a pilot tuberculosis literacy and treatment counselling intervention: a mixed methods study.

Authors:  Stephanie Law; Boitumelo Seepamore; Olivia Oxlade; Nondumiso Sikhakhane; Halima Dawood; Sheldon Chetty; Nesri Padayatchi; Dick Menzies; Amrita Daftary
Journal:  BMC Infect Dis       Date:  2021-05-18       Impact factor: 3.090

6.  Multidrug-resistant tuberculosis patients' views of interventions to reduce treatment loss to follow-up.

Authors:  T Tupasi; A M C G Garfin; J M Mangan; R Orillaza-Chi; L C Naval; G I Balane; R Basilio; A Golubkov; E S Joson; W-J Lew; V Lofranco; M Mantala; S Pancho; J N Sarol; A Blumberg; D Burt; E V Kurbatova
Journal:  Int J Tuberc Lung Dis       Date:  2017-01-01       Impact factor: 2.373

7.  Beyond pills and tests: addressing the social determinants of tuberculosis.

Authors:  Tom Wingfield; Marco A Tovar; Doug Huff; Delia Boccia; Matthew J Saunders; Sumona Datta; Rosario Montoya; Eric Ramos; James J Lewis; Robert H Gilman; Carlton Evans
Journal:  Clin Med (Lond)       Date:  2016-12       Impact factor: 2.659

8.  Mobile phone text messaging for promoting adherence to anti-tuberculosis treatment: a systematic review protocol.

Authors:  Mweete D Nglazi; Linda-Gail Bekker; Robin Wood; Gregory D Hussey; Charles S Wiysonge
Journal:  Syst Rev       Date:  2013-01-16

9.  Poor outcomes in a cohort of HIV-infected adolescents undergoing treatment for multidrug-resistant tuberculosis in Mumbai, India.

Authors:  Petros Isaakidis; Roma Paryani; Samsuddin Khan; Homa Mansoor; Mamta Manglani; Asmaa Valiyakath; Peter Saranchuk; Jennifer Furin
Journal:  PLoS One       Date:  2013-07-19       Impact factor: 3.240

10.  Community health workers augment the cascade of TB detection to care in urban slums of two metro cities in India.

Authors:  Rajaram Subramanian Potty; Karthikeyan Kumarasamy; Rajesham Adepu; Ramesh Chandra Reddy; Anil Singarajipura; Poornima Bathi Siddappa; Prarthana B Sreenivasa; Raghavendra Thalinja; Mohan Harnahalli Lakkappa; Reuben Swamickan; Amar Shah; Vikas Panibatla; Ramesh Dasari; Reynold Washington
Journal:  J Glob Health       Date:  2021-07-17       Impact factor: 4.413

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.